Literature DB >> 2967431

The myotonic mouse mutant ADR: physiological and histochemical properties of muscle.

J Reininghaus1, E M Füchtbauer, K Bertram, H Jockusch.   

Abstract

The muscle physiology and histochemistry of a hereditary neuromuscular syndrome of the mouse, "arrested development of righting response" (ADR), was studied. The speed of single twitches of fast ADR limb muscles was normal up to an age of about 60 days but decreased at later ages. At any age between 10 and 120 days postnatal, fast and slow muscles of the mutant displayed after-contractions of 1-3 (5) seconds duration. These coincided with electrical after-activity of muscle, as demonstrated by electromyography. After-contractions and EMG signals were suppressed by the membrane-stabilizing drug tocainide. These physiological data suggest that ADR is a myotonia. With a few exceptions, limb and trunk muscles of ADR animals showed a uniform oxidative phenotype with a lack of large diameter glycolytic fibers. The histochemical muscle phenotype of the ADR mouse was partially reversed by a long-term treatment with tocainide.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2967431     DOI: 10.1002/mus.880110504

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  11 in total

1.  Evidence for genetic homogeneity in autosomal recessive generalised myotonia (Becker).

Authors:  M C Koch; K Ricker; M Otto; F Wolf; B Zoll; C Lorenz; K Steinmeyer; T J Jentsch
Journal:  J Med Genet       Date:  1993-11       Impact factor: 6.318

2.  The structure of the mouse parvalbumin gene.

Authors:  M Schleef; C Zühlke; H Jockusch; F Schöffl
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

3.  Targeted splice sequencing reveals RNA toxicity and therapeutic response in myotonic dystrophy.

Authors:  Matthew K Tanner; Zhenzhi Tang; Charles A Thornton
Journal:  Nucleic Acids Res       Date:  2021-02-26       Impact factor: 16.971

4.  Activation of the MEF2 transcription factor in skeletal muscles from myotonic mice.

Authors:  Hai Wu; Eric N Olson
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

5.  Sodium channel slow inactivation as a therapeutic target for myotonia congenita.

Authors:  Kevin R Novak; Jennifer Norman; Jacob R Mitchell; Martin J Pinter; Mark M Rich
Journal:  Ann Neurol       Date:  2015-01-09       Impact factor: 10.422

6.  Fatigue-inducing stimulation resolves myotonia in a drug-induced model.

Authors:  Erik van Lunteren; Sarah E Spiegler; Michelle Moyer
Journal:  BMC Physiol       Date:  2011-02-28

7.  Developmental control of the excitability of muscle: transplantation experiments on a myotonic mouse mutant.

Authors:  E M Füchtbauer; J Reininghaus; H Jockusch
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

8.  Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy.

Authors:  Robert J Osborne; Xiaoyan Lin; Stephen Welle; Krzysztof Sobczak; Jason R O'Rourke; Maurice S Swanson; Charles A Thornton
Journal:  Hum Mol Genet       Date:  2009-02-17       Impact factor: 6.150

9.  Immunohistological analyses of neutral glycosphingolipids and gangliosides in normal mouse skeletal muscle and in mice with neuromuscular diseases.

Authors:  M Cacic; K Sostarić; S Weber-Schürholz; J Müthing
Journal:  Glycoconj J       Date:  1995-10       Impact factor: 2.916

10.  Impaired Wheel Running Exercise in CLC-1 Chloride Channel-Deficient Myotonic Mice.

Authors:  Erik van Lunteren; Michelle Moyer; Jessica Cooperrider; Jennifer Pollarine
Journal:  Front Physiol       Date:  2011-08-09       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.